Active site binding modes of curcumin in HIV-1 protease and integrase

被引:100
|
作者
Vajragupta, O
Boonchoong, P
Morris, GM
Olson, AJ
机构
[1] Mahidol Univ, Fac Pharm, Dept Pharmaceut Chem, Bangkok 10400, Thailand
[2] Ubon Rajathanee Univ, Fac Pharmaceut Sci, Div Pharmaceut Chem & Technol, Ubon Ratchathani 34190, Thailand
[3] Scripps Res Inst, Dept Mol Biol, Mol Graph Lab, La Jolla, CA 92037 USA
关键词
curcumin; HIV-1; HIV integrase; HIV protease; 5-CITEP; docking;
D O I
10.1016/j.bmcl.2005.05.032
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structure models for the interaction of curcumin with HIV-1 integrase (IN) and protease (PR) were investigated using computational docking. Curcumin was found to bind preferentially in similar ways to the active sites of both IN and PR. For IN, the binding site is formed by residues Asp64, His67, Thr66, Glu92, Thr93, Asp116, Ser119, Asn120, and Lys159. Docked curcumin contacts the catalytic residues adjacent to Asp116 and Asp64, and near the divalent metal (Mg2+). In the PR docking, the curcumin structure fitted well to the active site, interacting with residues Asp25, Asp29, Asp30, Gly27', Asp29', and Asp30'. The results suggest that o-hydroxyl and/or keto-enol structures are important for both IN and PR inhibitory actions. The symmetrical structure of curcumin seems to play an important role for binding to the PR protein, whereas the keto-enol and only one side of the terminal o-hydroxyl showed tight binding to the IN active site. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3364 / 3368
页数:5
相关论文
共 50 条
  • [1] Binding modes of HIV-1 integrase inhibitors at the active site
    Sotriffer, CA
    Ni, HH
    McCammon, JA
    RATIONAL APPROACHES TO DRUG DESIGN, 2001, : 83 - 87
  • [2] Active site binding modes of HIV-1 integrase inhibitors
    Sotriffer, CA
    Ni, HH
    McCammon, JA
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (22) : 4109 - 4117
  • [3] Active site binding modes of dimeric phloroglucinols for HIV-1 reverse transcriptase, protease and integrase
    Gupta, Pawan
    Kumar, Rajender
    Garg, Prabha
    Singh, Inder Pal
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (15) : 4427 - 4431
  • [4] Active site binding modes of the β-diketoacids:: a multi-active site approach in HIV-1 integrase inhibitor design
    Dayam, R
    Neamati, N
    BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (24) : 6371 - 6381
  • [5] Correlation of biological activity with active site binding modes of geminal disulfone HIV-1 integrase inhibitors
    Meadows, D. Christopher
    Tantillo, Dean J.
    Gervay-Hague, Jacquelyn
    CHEMMEDCHEM, 2006, 1 (09) : 959 - +
  • [6] HIV-1 integrase inhibitor interactions at the active site: Prediction of binding modes unaffected by crystal packing
    Sotriffer, CA
    Ni, HH
    McCammon, JA
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2000, 122 (25) : 6136 - 6137
  • [7] The active site of HIV-1 protease
    Mager, PP
    MEDICINAL RESEARCH REVIEWS, 2001, 21 (04) : 348 - 353
  • [8] Identification of a nucleotide binding site in HIV-1 integrase
    Drake, R. R.
    Neamati, N.
    Hong, H.
    Pilon, A. A.
    Proceedings of the National Academy of Sciences of the United States of America, 95 (08):
  • [9] Identification of a monoclonal antibody binding site of HIV-1 integrase
    Yi, JZ
    Skalka, AM
    FASEB JOURNAL, 1999, 13 (07): : A1503 - A1503
  • [10] Binding modes of two novel dinucleotide inhibitors of HIV-1 integrase
    Guenther, S
    Nair, V
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (16) : 2233 - 2236